ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Aspire Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Aspire Pharmaceuticals INC. (Aspire Pharmaceuticals INC. 401(k) Plan · EIN 26-4768954 · PN 001): $4.95M net assets, 138 active participants, and $25.96 per $10,000 (25.96 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAspire Pharmaceuticals INC.
Filing IdentifierAspire Pharmaceuticals INC. 401(k) Plan · EIN 26-4768954 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$1M-$5M
Plan Net Assets (2024)$4.95M
Active Participants138
Direct Admin Fee Rate$25.96 per $10,000 (25.96 bps)
Cohort Peer Median$63.02 per $10,000 (63.02 bps)
Primary Recordkeeper / ProviderADP Retirement Services
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI